Vivo Bio Tech (BOM:532660) allotted 740,000 equity shares at 45 Indian rupees each upon conversion of warrants issued on a preferential basis, according to an Indian bourse filing on Monday.
The company received around 25 million rupees in application money, the filing said.
Following the allotment, the company's issued and subscribed share capital increased to 168.7 million rupees, comprising 16.9 million equity shares of 10 rupees each.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.